Cell surface ATP synthase (Ecto-ATP synthase)

ATP synthase, traditionally localized to the inner mitochondrial membrane, is also found on the plasma membrane of several cell types, most notably endothelial cells, where it is referred to as ecto-ATP synthase (Moser et al., 1999, PNAS). In this ectopic location, the enzyme functions to synthesize or hydrolyze ATP in the extracellular space, thereby regulating extracellular ATP levels and maintaining the intracellular pH gradient required for cell movement (Chi and Pizzo, 2006, Cancer Res). This cell surface expression is significantly upregulated under conditions of stress, such as hypoxia and low pH, which are characteristic of the tumor microenvironment (Yamamoto et al., 2007, Drug Discovery Today). Consequently, ecto-ATP synthase plays a pivotal role in tumor-associated angiogenesis by promoting the proliferation and migration of endothelial cells. Therapeutic strategies targeting this enzyme, such as the use of angiostatin or specific antibodies, aim to inhibit its catalytic activity to suppress tumor vascularization. Because its expression is relatively specific to activated endothelial cells and certain tumor cells compared to normal resting tissues, it represents a selective target for anti-angiogenic and anti-cancer therapies.

Other names

Endothelial cell surface ATP synthaseEctopic ATP synthaseCell surface F1F0-ATP synthaseEcto-F1F0-ATP synthasePlasma membrane ATP synthase

Inhibition of the catalytic activity (ATP synthesis or hydrolysis) of the cell surface-localized ATP synthase complex, which disrupts the energetic and ionic environment necessary for endothelial cell proliferation and migration, thereby inhibiting angiogenesis.